The pulmonary deposition and retention of indium-111 labeled ultrafine carbon particles in healthy individuals

References

• Boffetta P, Jourenkova N, Gustavsson P. 1997. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control 8:444–472.
   PubMed Web of Science ®Google Scholar
• Brown JS, Zeman KL, Bennett WD. 2002. Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med 166:1240–1247.
   PubMed Web of Science ®Google Scholar
• Burch WM, Sullivan PJ, McLaren CJ. 1986. Technegas–a new ventilation agent for lung scanning. Nucl Med Commun 7:865–871.
   PubMed Web of Science ®Google Scholar
• Camner P, Philipson K. 1978. Human alveolar deposition of 4 micron teflon particles. Arch Environ Health 33:181–185.
   PubMed Web of Science ®Google Scholar
• Donaldson K, Stone V, Clouter A, Renwick L, MacNee W. 2001. Ultrafine particles. Occup Environ Med 58:211–6, 199.
   PubMed Web of Science ®Google Scholar
• Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, Potter R, Maynard A, Ito Y, Finkelstein J, Oberdörster G. 2006. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 114:1172–1178.
   PubMed Web of Science ®Google Scholar
• Ghio AJ, Bennett WD. 2007. Metal particles are inappropriate for testing a postulate of extrapulmonary transport. Environ Health Perspect 115:A70; author reply A70–A70; author reply A71.
   Google Scholar
• Kreyling WG, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H, Oberdörster G, Ziesenis A. 2002. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health Part A 65:1513–1530.
   PubMed Web of Science ®Google Scholar
• Kreyling WG, Semmler-Behnke M, Seitz J, Scymczak W, Wenk A, Mayer P, Takenaka S, Oberdörster G. 2009. Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol 21 Suppl 1:55–60.
   PubMedGoogle Scholar
• Li XY, Gilmour PS, Donaldson K, MacNee W. 1997. In vivo and in vitro proinflammatory effects of particulate air pollution (PM10). Environ Health Perspect 105 Suppl 5:1279–1283.
   PubMedGoogle Scholar
• Mills NL, Amin N, Robinson SD, Anand A, Davies J, Patel D, de la Fuente JM, Cassee FR, Boon NA, Macnee W, Millar AM, Donaldson K, Newby DE. 2006. Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am J Respir Crit Care Med 173:426–431.
   PubMed Web of Science ®Google Scholar
• Möller W, Felten K, Sommerer K, Scheuch G, Meyer G, Meyer P, Häussinger K, Kreyling WG. 2008. Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. Am J Respir Crit Care Med 177:426–432.
   PubMed Web of Science ®Google Scholar
• Monteiller C, Tran L, MacNee W, Faux S, Jones A, Miller B, Donaldson K. 2007. The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. Occup Environ Med 64:609–615.
   PubMed Web of Science ®Google Scholar
• Morrow PE. 1973. Alveolar clearance of aerosols. Arch Intern Med 131:101–108.
   PubMed Web of Science ®Google Scholar
• Nemmar A, Hoet PH, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts MF, Vanbilloen H, Mortelmans L, Nemery B. 2002. Passage of inhaled particles into the blood circulation in humans. Circulation 105:411–414.
   PubMed Web of Science ®Google Scholar
• Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C. 2004. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 16:437–445.
   PubMed Web of Science ®Google Scholar
• Philipson K, Falk R, Camner P. 1985. Long-term lung clearance in humans studied with Teflon particles labeled with chromium-51. Exp Lung Res 9:31–42.
   PubMed Web of Science ®Google Scholar
• Philipson K, Falk R, Gustafsson J, Camner P. 1996. Long-term lung clearance of 195Au-labeled teflon particles in humans. Exp Lung Res 22:65–83.
   PubMed Web of Science ®Google Scholar
• Pope CA 3rd, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD. 2002. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 287:1132–1141.
   PubMed Web of Science ®Google Scholar
• Pope CA 3rd, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, Godleski JJ. 2004. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation 109:71–77.
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. 1993. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 16:5–40.
   PubMedGoogle Scholar
• Renwick LC, Brown D, Clouter A, Donaldson K. 2004. Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types. Occup Environ Med 61:442–447.z
   PubMed Web of Science ®Google Scholar
• Sanchez-Crespo A, Klepczynska-Nyström A, Lundin A, Larsson BM, Svartengren M. 2011. 111Indium-labeled ultrafine carbon particles; a novel aerosol for pulmonary deposition and retention studies. Inhal Toxicol 23:121–128.
   PubMed Web of Science ®Google Scholar
• Semmler M, Seitz J, Erbe F, Mayer P, Heyder J, Oberdörster G, Kreyling WG. 2004. Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal Toxicol 16:453–459.
   PubMed Web of Science ®Google Scholar
• Svartengren K, Ericsson CH, Svartengren M, Mossberg B, Philipson K, Camner P. 1996. Deposition and clearance in large and small airways in chronic bronchitis. Exp Lung Res 22:555–576.
   PubMed Web of Science ®Google Scholar
• Svartengren M, Svartengren K, Europe E, Falk R, Hofmann W, Sturm R, Philipson K, Camner P. 2004. Long-term clearance from small airways in patients with chronic bronchitis: experimental and theoretical data. Exp Lung Res 30:333–353.
   PubMed Web of Science ®Google Scholar
• Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, Schramel P, Heyder J. 2001. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect 109 Suppl 4:547–551.
   PubMed Web of Science ®Google Scholar
• Takenaka S, Karg E, Kreyling WG, Lentner B, Möller W, Behnke-Semmler M, Jennen L, Walch A, Michalke B, Schramel P, Heyder J, Schulz H. 2006. Distribution pattern of inhaled ultrafine gold particles in the rat lung. Inhal Toxicol 18:733–740.
   PubMed Web of Science ®Google Scholar
• Wiebert P, Sanchez-Crespo A, Falk R, Philipson K, Lundin A, Larsson S, Möller W, Kreyling WG, Svartengren M. 2006a. No significant translocation of inhaled 35-nm carbon particles to the circulation in humans. Inhal Toxicol 18:741–747.
   PubMed Web of Science ®Google Scholar
• Wiebert P, Sanchez-Crespo A, Seitz J, Falk R, Philipson K, Kreyling WG, Möller W, Sommerer K, Larsson S, Svartengren M. 2006b. Negligible clearance of ultrafine particles retained in healthy and affected human lungs. Eur Respir J 28:286–290.
   PubMed Web of Science ®Google Scholar